|
Press Releases
6.08 - Kamada Announces Successful Interim Results of Phase II Deposition Study with Aerosolized AAT
4.08 - PARI's eFlow delivers Alnylam RNAi Therapeutic in Phase II study
3.08 -  PARI Nebulizer & Compressor Used Exclusively in Inspire's Phase 3 CF Trial
2.08 - PARI and Kamada Expand Collaboration for Additional Inhaled AAT Indications
1.08 - PARI and Kamada Announce Successful Phase I Results for Aerosolized Alpha-1 Antitrypsin (AAT)
12.07 - PARI's eFlow delivers Alnylam RNAi Therapeutic in Phase I study
11.07 - PARI's eFlow included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation
10.07 - Study Using PARI Nebulizer Finds COPD Therapy of Nebulizer and Inhaler Combo More Effective than Inhaler Alone
10.07 - PARI Respiratory's LC Plus and PRONEB Ultra Deliver Dey, L.P.'s New COPD Therapy; Perforomist Launched Yesterday
9.07 - Pediatric Asthma Programs featuring PARI Pharma's eFlow Acquired by AstraZeneca
6.07 - PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
5.07 - PARI and Kamada
5.07 - Gilead's Phase III, PARI's eFlow Delivers
3.07 - PARI's Hydrate™ Receives FDA 510k Clearance
1.07 - PARI's eFlow® Wins Good Design Award
12.06 - NIH using PARI's eFlow® in HIV/AIDS Vaccine Research
11.06 - PARI's Hydrate™ to be Showcased at the AARC Congress
11.06 - PARI's eFlow® in Cystic Fibrosis Clinical Trial of L-arginine
11.06 - PARI and Kamada collaborate to Develop Inhaled alpha-1 Antitrypsin
10.06 - PARI's eFlow® Nebulizer used in Alnylam clinical Trial for Respiratory Syncytial Virus
10.06 - PARI's Trek and LC® Plus Deliver Sepracor's new COPD medication
9.06 - PARI Respiratory Launches Nasal Drug Delivery Program
9.06 - PARI Launches PRONEB® Ultra II Compressor
7.06 - PARI Launches LC® Plus Nebulizer and Trek® S Compact Compressor
6.06 - PARI & BOC in Collaboration to Develop Innovative Drug Delivery Systems
6.06 - PARI Celebrates 100 Years of Aerosol Delivery
6.06 - PARI Named Leading Nebulizer Company in Cambridge Consulting Survey
|
